| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 245 / 278 | 12th | Q4 |
| Pharmacology, Toxicology and Pharmaceutics (all) | 73 / 79 | 8th | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Chinese Journal of New Drugs
Chinese Journal of New Drugs is Scopus-indexed (Q4, CiteScore 0.5). Published by Chinese Journal of New Drugs Co. Ltd..
Checked against the index lists dated .
ISSN 1003-3734Verify ISSN ↗
Publisher: Chinese Journal of New Drugs Co. Ltd.
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Chinese Journal of New Drugs indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q4, CiteScore 0.5.
What quartile is Chinese Journal of New Drugs in Scopus?
Chinese Journal of New Drugs is Q4 in Pharmacology (medical) (rank 245 of 278) and Q4 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 73 of 79), by CiteScore 2025.
What is the impact factor of Chinese Journal of New Drugs?
Chinese Journal of New Drugs is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.5, quartile Q4, 12th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.127, quartile Q4, with an H-index of 15.
Who publishes Chinese Journal of New Drugs and what is its ISSN?
Chinese Journal of New Drugs is published by Chinese Journal of New Drugs Co. Ltd. Its ISSN is 1003-3734.
Is Chinese Journal of New Drugs in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Chinese Journal of New Drugs open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Chinese Journal of New Drugs? — open metrics via OpenAlex
Chinese Journal of New Drugs has an h-index of 10 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 0.5, quartile Q4. On 2-year citations it ranks #250 of 271 Scopus journals in Pharmacology (medical).
Chinese Journal of New Drugs published 12 papers in 2021; its busiest recent year was 2010 with 456. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Are there integrity warnings for Chinese Journal of New Drugs? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.